Warfarin and Antiplatelet Vascular Evaluation

Active, not recruiting

Phase 3 Results N/A

Summary of Purpose

The purpose of this study is to evaluate whether the addition of warfarin (a blood-thinning medication) to an antiplatelet therapy like aspirin is better than antiplatelet therapy alone (i.e. usual treatment) for the prevention of leg surgery, heart attacks, stroke and death in people with peripheral vascular disease.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 September 2009.

1 Jan 2000 29 Jul 2005 Unavailable 1 Apr 2006 1 Sep 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Study Coordinating Centre Canadian Cardiovascular Collaboration (CCC) Office Population Health Research Institute 237 Barton Street East Hamilton, ON L8L 2X2 E-mail: wave@ccc.mcmaster.ca

    wave@ccc.mcmaster.ca